Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-30Clinical Trial Update: Remote Monitoring of Patients at Risk of Sepsis [NA]
A trial investigating remote monitoring of patients at risk of sepsis, including those with neutropenia and cancer, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-19Clinical Trial Update: Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent [EARLY_Phase 1]
A Phase 1 trial comparing percutaneous renal versus endoscopic stents for cancer-related urinary tract obstruction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Supporting Spiritual Wellbeing in Young Adults With Cancer Using a Digital Health Approach: A Feasibility Study [NA]
A feasibility trial evaluating a digital health approach to support spiritual wellbeing in young adults with cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-14Clinical Trial Update: Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray [Phase 4]
Phase 4 clinical trial evaluating EMLA cream versus nüm Vapocoolant Spray for reducing port access pain and clinic wait times has been withd…
-
CLINICAL_TRIALS withdrawal · 2024-11-07Clinical Trial Update: Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies
The long-term follow-up safety study of SynKIR-110 in cancer studies has been withdrawn from clinical trials records.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-10-23Clinical Trial Update: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use [Phase 2]
A Phase II randomized trial evaluating augmented reality gaming to reduce postoperative opioid use in opioid-tolerant pediatric cancer patie…
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy [EARLY_Phase 1]
A Phase 1 trial evaluating transcranial direct current stimulation to reduce pain in cancer patients with chemotherapy-induced peripheral ne…
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients [Phase 2]
A Phase 2 basket trial of the P10s-PADRE vaccine for metastatic cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Calibration of MR and PET-MR Imaging Protocols at RIC [NA]
The trial update notes withdrawal of a study on calibrating MR and PET-MR imaging protocols at RIC; no results or ongoing activities reporte…
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: Cope 360 App for Caregivers of Children With Cancer [NA]
The clinical trial NCT05112458 evaluating the Cope 360 App for caregivers of children with cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-12Clinical Trial Update: Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid Patients. [NA]
A clinical trial evaluating geriatric and oncological assessment using technology for holistic healthcare management in older multimorbid pa…
-
CLINICAL_TRIALS withdrawal · 2024-07-30Clinical Trial Update: Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
The MAFIC Study, a clinical trial on managing atrial fibrillation in cancer patients, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-28Clinical Trial Update: E-Care Acceptability for Older People Undergoing Chemotherapy [NA]
The clinical trial NCT05408195 on E-Care acceptability for older people undergoing chemotherapy has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: Oncology Associated Symptoms & Individualized Strategies [NA]
Clinical trial update indicates the study on oncology-associated symptoms and individualized strategies for advanced cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2022-07-18Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer [Phase 3]
Phase 3 trial evaluating metabolic combination treatments for cancer has been withdrawn.
-
EMA withdrawal · 2022-04-08EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG
Palonosetron Hospira (palonosetron hydrochloride) has been withdrawn in the EMA system.
-
CLINICAL_TRIALS withdrawal · 2022-04-01Clinical Trial Update: Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects [Phase 3]
Phase 3 trial comparing atomoxetine to placebo for cognitive late effects in cancer patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-12-10Clinical Trial Update: Nasal Fentanyl for Chronic Cancer Pain [Phase 3]
Phase 3 trial of nasal fentanyl for chronic cancer pain was withdrawn.
-
EMA withdrawal · 2020-03-02EMA Withdrawn: Varuby (rolapitant) — TESARO Bio Netherlands B.V.
EMA has withdrawn Varuby (rolapitant) from the market in the Netherlands/EMA record; the withdrawal concerns vomiting, nausea, and cancer in…
-
CLINICAL_TRIALS withdrawal · 2019-11-29Clinical Trial Update: Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects [Phase 4]
A Phase 4 clinical trial evaluating subcutaneous methylnaltrexone for opioid-induced constipation in cancer patients has been withdrawn.
-
EMA withdrawal · 2019-04-26EMA recommends withdrawal of marketing authorisation for cancer medicine Lartruvo
EMA recommends withdrawing the marketing authorisation for the cancer medicine Larotrectinib (Lartruvo) due to safety concerns and lack of o…
-
CLINICAL_TRIALS withdrawal · 2018-05-31Clinical Trial Update: Implementation of a Delirium Screening [NA]
The University of Miami-sponsored clinical trial on delirium screening in cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: Anabolic Response Cancer [NA]
A Texas A&M University–sponsored clinical trial (NCT02793531) investigating anabolic response in cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy [NA]
The clinical trial investigating Tai Chi Easy for cancer survivors with peripheral sensory neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-05Clinical Trial Update: An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients. [Phase 4]
A Phase 4 clinical trial evaluating fentanyl citrate nasal spray for breakthrough pain in cancer patients has been withdrawn.